G

Guardian Pharmacy Services

Decentralized LTC pharmacy with national support

Billing Specialist

Full-Time
$22 - $26+ 401(k) Match
Junior
Minneapolis, MN, USA
In Person
AccountingAccounts Payable/Receivable

About the job

Requirements
  • A high school diploma or GED is required.
  • A pharmacy technician license, certification, or registration is required as specified by state requirements; national certification through PTCB may be required for pharmacy-specific positions.
  • At least one year of related experience is required.
  • Advanced computer skills are required.
  • Ability to work independently and meet deadlines is required.
  • Attention to detail and accuracy are required.
  • Ability to work on multiple tasks simultaneously while adhering to strict deadlines is required.
  • A quality-focused approach, including identifying errors and investigating inaccuracies, is required.
  • Ability to interact effectively with others in an office environment, manage conflict, and handle stressful situations and deadlines is required.
  • Ability to work flexible hours is required.
Responsibilities
  • Process customer bills and insurance claims accurately and promptly, assisting with daily and month-end billing functions, procedures, and reporting.
  • Research and establish patient eligibility and insurance coverage with private and government insurance providers; reverify benefit coverage as needed for claims follow-up; and enter or update patient and insurance information in billing systems.
  • Maintain and continually audit patient files and documentation needed to support third-party audits and ensure payer and company compliance; accurately enter patient information into the pharmacy system.
  • Respond promptly to billing inquiries from patients, caregivers, medical providers, and insurance carriers by phone or electronic communication; research and resolve issues involving insurance eligibility, coverage, and related benefits.
  • Run Medicare plan comparisons during open enrollment and special enrollment periods, and review patient profiles, drug regimens, and insurance coverage to evaluate cost-saving options for residents.
  • Complete daily census, admissions, discharges, and room changes for assigned facilities.
  • Process patient payments, returns, and credits, and transmit individual credit card payments as needed.
  • Pursue payment from delinquent accounts and make payment arrangements as needed.
  • Research, identify, and organize requested audit documentation promptly.
  • Adjudicate prescription claims, communicate with insurance companies about rejected claims, eligibility, prior authorizations, and other issues, correct issues, and rebill claims as necessary.
  • Develop knowledge of pharmacy facility billing requirements, including Medicare, Medicaid, prescription drug plans, and third-party insurance.
  • Develop proficiency with pharmacy information systems to meet operational and regulatory needs, including processing prior authorizations, resolving rejections, producing reports, and completing billing functions.
  • Rotate through other departments to gain working knowledge of their workflows.
  • Follow applicable government regulations, including HIPAA.
  • Work collaboratively with the pharmacy team to meet service goals.
  • Perform other essential duties as assigned.
Desired Qualifications
  • Pharmacy information system experience is preferred.
  • National pharmacy technician certification through PTCB is preferred, though it may be required for pharmacy-specific positions.

About the company

G

Guardian Pharmacy Services

View

Guardian Pharmacy Services runs a network of long-term care pharmacies in the United States using a local-autonomy model, where each pharmacy operates as a local business with some owner-ship by local managers while a national team provides centralized support. It dispenses medications and offers medication management, 24/7 access, advanced packaging, and clinical support from pharmacists who specialize in geriatric and complex care, backed by GuardianShield data analytics to aid facility decisions. The company serves residents in assisted living, memory care, skilled nursing, hospice, and related settings across 38 states, with a national footprint of over 53 pharmacies serving more than 204,000 residents. Its goal is to improve medication safety and adherence while reducing overall healthcare costs through tailored, community-focused care and scalable corporate resources.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Atlanta, Georgia

Founded

2004

Get referred to Guardian Pharmacy Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Guardian raised 2026 revenue guidance to $1.43 billion-$1.45 billion on August 6, 2026.
  • Wellness Concepts and Nautilus acquisitions expand Virginia and Tennessee reach, adding local density.
  • Resident counts and script volumes grew 10% in Q1 2026, supporting operating leverage.

What critics are saying

  • IRA pricing cuts already forced 60% declines on selected drugs, pressuring 2026 revenue.
  • Executive turnover hit June 2026: Kendall Forbes retires, while David Morris becomes COO.
  • Nautilus mail-order customers across 14 states face transition risk during Guardian integration through 2026.

What makes Guardian Pharmacy Services unique

  • Guardian’s decentralized pharmacy model keeps local management invested, scaling with national support.
  • Guardian serves 207,000 residents across 38 states, creating dense LTC relationships and switching costs.
  • GuardianShield data analytics and 24/7 clinical support differentiate care economics for facilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Health Savings Account/Flexible Spending Account
  • Life Insurance
  • Disability Insurance
  • 401(k) Company Match
  • Paid Holidays
  • Paid Sick Leave
  • Paid Vacation
  • Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

15%

1 year growth

15%

2 year growth

15%
Yahoo Finance
Aug 13th, 2026
Guardian Pharmacy Services grows revenue 2% in Q2 2026 despite IRA pricing impact

Guardian Pharmacy Services reported second quarter 2026 results, with revenue growing 2% through the first half of the year. Chief Executive Officer Fred Burke noted the company would have seen low double-digit revenue growth excluding IRA pricing reductions, which he described as a clearer indication of underlying business growth. The company attributed its performance to solid fundamentals across local markets and progress on strategic priorities, including geographic expansion. Burke emphasised that Guardian continues to execute well despite pricing pressures. The results covered the quarter ended 30 June 2026. Company executives, including Burke, Chief Operating Officer David Morris, and Chief Financial Officer Will Mudd, discussed the performance during an earnings call.

Business Wire
Jul 2nd, 2026
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts

Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia.

Yahoo Finance
May 10th, 2026
Guardian Pharmacy navigates IRA pricing changes with 19% gross profit growth in Q1

Guardian Pharmacy Services reported first-quarter 2026 revenue of $336.6 million, up 2% year over year, despite significant pricing pressure from the Inflation Reduction Act's new framework. CEO Fred Burke said the company experienced approximately 60% price declines on IRA-selected drugs, noting that revenue would have grown by low double digits without these government-mandated reductions. The company reported gross profit of $76 million, up 19% year over year, with adjusted EBITDA rising 27% to $29.8 million. Total residents increased 10% to approximately 207,000, with script volumes also up 10%. CFO David Morris attributed growth to organic expansion, acquisitions and plan optimisation efforts. Guardian raised its adjusted EBITDA guidance whilst maintaining its full-year revenue outlook following the quarter.

Yahoo Finance
May 8th, 2026
Guardian Pharmacy offsets 60% IRA-driven branded drug pricing decline with 2% Q1 revenue growth

Guardian Pharmacy Services reported 2% revenue growth in Q1 2026, offsetting a 60% decline in branded drug pricing from the Inflation Reduction Act through renegotiated payer contracts. The company updated full-year adjusted EBITDA guidance to $123 million–$127 million, reflecting a $3 million discrete first-quarter benefit. Underlying fundamentals remained strong, with 10% year-over-year growth in resident count and prescription volumes. However, operational complexity increased due to Medicare's new Transaction Facilitator platform, causing working capital timing shifts expected to normalise throughout the year. Results included $3.2 million in legal expenses for reimbursement advocacy, with an $8.5 million settlement to be recognised in Q2. Recent acquisitions dampened margins by 80 basis points. Management expects labour costs to rise modestly as the company invests in regional leadership whilst maintaining its acquisition pace.

Bitget
Mar 18th, 2026
Guardian's $21 synthetic secondary suggests undervaluation as 35% discount reflects earnings momentum

Guardian Pharmacy Services has priced a follow-on offering at $21 per share, raising approximately $181 million in a synthetic secondary. The offering price represents a 35% discount to the previous closing price of $32.59, though the stock had already declined 2.60% over the past month. The company reported strong 2025 results, with revenue of $1.45 billion (up 18%) and adjusted EBITDA of $115.1 million (up 53%). Management raised 2026 EBITDA guidance to $120–$124 million, but revenue projections remain flat at $1.40–$1.42 billion, signalling a growth slowdown. Guardian's shares trade at a trailing P/E of 55.19, with a market capitalisation near $2.20 billion. Analysts rate the stock a moderate buy with a price target around $32, indicating limited upside as the market has absorbed recent earnings surprises.